Key Details
Price
$122.66Last Dividend
$0.51Annual ROE
-26.52%Beta
0.17Events Calendar
Next earnings date:
May 02, 2025Recent quarterly earnings:
Jan 30, 2025Recent annual earnings:
Aug 14, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Jan 02, 2025Next split:
N/ARecent split:
Apr 23, 2001Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Cardinal Health, Inc. (NYSE:CAH) will hold its Q2 2025 Earnings Conference Call on January 30, 2025, at 8:30 AM ET. The call will feature company representatives including Matt Sims, Jason Hollar, and Aaron Alt, along with participants from various financial institutions. The event will be coordinated by George, who will guide the discussion.
The Zacks Style Scores help investors quickly identify highly-rated stocks that match their investment preferences. Here are some reasons to make the most of this tool.
Cardinal Health (CAH) reported quarterly earnings of $1.93 per share, which is higher than the Zacks Consensus Estimate of $1.75 per share. This is an increase compared to earnings of $1.82 per share from the same period last year.
On Thursday, Cardinal Health, a drug distributor, increased its profit expectations for fiscal 2025. This change is due to high demand for expensive specialty medicines and branded drugs, which boosted sales in its pharmaceuticals division.
Cardinal Health reported a revenue of $55.3 billion for the second quarter of fiscal year 2025, which is a 4% decrease compared to the same period last year. However, if we exclude the effects of a major customer contract ending, revenue actually rose by 16%. The company also announced that it has completed its acquisition of a 73% stake in GI Alliance.
In the second quarter of fiscal 2025, Cardinal Health saw strong revenue growth in its Other segment. However, the expiration of the OptumRx contract negatively impacted sales in the Pharmaceutical segment.
Even with the recent issues in the supply chain, the opening of new facilities and an increase in sales of branded and specialty pharmaceuticals probably helped CAH perform well in the second quarter of the fiscal year.
Cardinal (CAH) has the right mix of two important factors that could lead to better earnings in its next report. Get ready for the main expectations.
This is a comparison of how Cardinal Health (CAH) and AIM ImmunoTech Inc. (AIM) have done in relation to their industry this year.
Cardinal Health (CAH) finished the last trading day at $127.83, which is an increase of 1.24% compared to the day before.
FAQ
- What is the primary business of Cardinal Health?
- What is the ticker symbol for Cardinal Health?
- Does Cardinal Health pay dividends?
- What sector is Cardinal Health in?
- What industry is Cardinal Health in?
- What country is Cardinal Health based in?
- When did Cardinal Health go public?
- Is Cardinal Health in the S&P 500?
- Is Cardinal Health in the NASDAQ 100?
- Is Cardinal Health in the Dow Jones?
- When was Cardinal Health's last earnings report?
- When does Cardinal Health report earnings?
- Should I buy Cardinal Health stock now?